Oruka Therapeutics, Inc. Common Stock (ORKA) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ORKA. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 249 institutions reported holding ORKA, with 74.1 million shares worth $7.1 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 9,057,645 | $862M | INCREASED |
| BlackRock | 4,990,181 | $475M | INCREASED |
| VR Adviser | 4,148,428 | $395M | UNCHANGED |
| Fairmount Funds Management | 3,705,262 | $353M | UNCHANGED |
| Capital Group | 3,401,639 | $324M | NEW |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Lawrence Otto Klein (Chief Executive Officer) | EXERCISE | 25,000 | $195K | 2026-11-02 |
| Lawrence Otto Klein (Chief Executive Officer) | SELL | 300 | $30K | 2026-11-02 |
| Lawrence Otto Klein (Chief Executive Officer) | SELL | 756 | $74K | 2026-11-02 |
| Lawrence Otto Klein (Chief Executive Officer) | SELL | 2,442 | $236K | 2026-11-02 |
| Lawrence Otto Klein (Chief Executive Officer) | SELL | 15,036 | $1M | 2026-11-02 |
Full institutional holdings, insider history, and congressional trades for Oruka Therapeutics, Inc. Common Stock on SentiSense.